English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and lsocitrate Dehydrogenase (IDH1) Driven Astrocytoma

Doll, S., Urisman, A., Oses-Prieto, J. A., Arnott, D., & Burlingame, A. L. (2017). Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and lsocitrate Dehydrogenase (IDH1) Driven Astrocytoma. Molecular and Cellular Proteomics, 16(1), 39-56. doi:10.1074/mcp.M116.063883.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/11858/00-001M-0000-002C-A106-5 Version Permalink: http://hdl.handle.net/11858/00-001M-0000-002C-A107-3
Genre: Journal Article

Files

show Files

Locators

show
hide
Locator:
http://www.mcponline.org/content/16/1/39 (Publisher version)
Description:
-

Creators

show
hide
 Creators:
Doll, Sophia1, Author              
Urisman, Anatoly2, Author
Oses-Prieto, Juan A.2, Author
Arnott, David2, Author
Burlingame, Alma L.2, Author
Affiliations:
1Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565159              
2external, ou_persistent22              

Content

show
hide
Free keywords: HUMAN GLIOBLASTOMA-MULTIFORME; ACTIVATED PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; POSTTRANSLATIONAL MODIFICATIONS; ONCOMETABOLITE 2-HYDROXYGLUTARATE; ANAPLASTIC ASTROCYTOMA; PHOSPHORYLATION SITES; EXPRESSION PROFILES; SIGNALING NETWORKS; CANCER-CELLSBiochemistry & Molecular Biology;
 Abstract: Glioblastoma multiformes (GBMs) are high-grade astrocytomas and the most common brain malignancies. Primary GBMs are often associated with disturbed HAS signaling, and expression of oncogenic HRAS results in a malignant phenotype in glioma cell lines. Secondary GBMs arise from lower-grade astrocytomas, have slower progression than primary tumors, and contain IDH1 mutations in over 70% of cases. Despite significant amount of accumulating genomic and transcriptomic data, the fundamental mechanistic differences of gliomagenesis in these two types of high-grade astrocytoma remain poorly understood. Only a few studies have attempted to investigate the proteome, phosphorylation signaling, and epigenetic regulation in astrocytoma. In the present study, we applied quantitative phosphoproteomics to identify the main signaling differences between oncogenic HRAS and mutant IDH1-driven glioma cells as models of primary and secondary GBM, respectively. Our analysis confirms the driving roles of the MAPK and PI3K/mTOR signaling pathways in HRAS driven cells and additionally uncovers dysregulation of other signaling pathways. Although a subset of the signaling changes mediated by HRAS could be reversed by a MEK inhibitor, dual inhibition of MEK and PI3K resulted in more complete reversal of the phosphorylation patterns produced by HRAS expression. In contrast, cells expressing mutant IDH1 did not show significant activation of MAPK or PI3K/mTOR pathways. Instead, global downregulation of protein expression was observed. Targeted proteomic analysis of histone modifications identified significant histone methylation, acetylation, and butyrylation changes in the mutant IDH1 ex pressing cells, consistent with a global transcriptional repressive state. Our findings offer novel mechanistic insight linking mutant IDH1 associated inhibition of histone demethylases with specific histone modification changes to produce global transcriptional repression in secondary glioblastoma. Our proteomic datasets are available for download and provide a comprehensive catalogue of alterations in protein abundance, phosphorylation, and histone modifications in oncogenic HRAS and IDH1 driven astrocytoma cells beyond the transcriptomic level.

Details

show
hide
Language(s): eng - English
 Dates: 2016-11-102017
 Publication Status: Published in print
 Pages: 18
 Publishing info: -
 Table of Contents: -
 Rev. Method: -
 Identifiers: ISI: 000392205300004
DOI: 10.1074/mcp.M116.063883
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Molecular and Cellular Proteomics
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Bethesda, MD : American Society for Biochemistry and Molecular Biology
Pages: - Volume / Issue: 16 (1) Sequence Number: - Start / End Page: 39 - 56 Identifier: ISSN: 1535-9476
CoNE: /journals/resource/111035577487002